Myprotein

Milk Thistle Dry Extract, the active ingredient in Myprotein, is a herbal supplement presented as a powdered extract for oral use. It is intended to support liver health and protect hepatocytes in adults. GNH USA supplies Myprotein as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Myprotein, containing milk thistle dry extract, is used to support liver‑related functions and protect hepatic cells. - Liver support: helps maintain normal liver enzyme levels and promotes healthy liver function. - Hepatoprotection: provides antioxidant protection against oxidative stress in liver tissue. - Detoxification assistance: may aid the body’s natural detox processes by supporting bile production.

Milk thistle dry extract is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Gastrointestinal discomfort: mild nausea, bloating or diarrhoea. - Headache: occasional mild headache. - Allergic skin reactions: rash or itching, especially in individuals sensitive to Asteraceae family plants.

Serious or Rare Side Effects: - Anaphylactic reaction: rare but potentially life‑threatening allergy. - Elevated liver enzymes: paradoxical increase in hepatic markers in very few cases. - Severe gastrointestinal bleeding: extremely uncommon.

Milk thistle dry extract should be used with awareness of specific safety considerations. - Pregnancy: safety not established; avoid unless prescribed. - Breastfeeding: insufficient data; use with caution. - Liver disease: consult a healthcare professional before use. - Drug interactions: monitor patients taking medications metabolised by CYP enzymes. - Allergy: avoid if known hypersensitivity to milk thistle or related plants. - Store at ambient temperature: keep in original container, protect from moisture and light.

Milk thistle dry extract can influence the activity of several drugs, requiring attention to potential interactions.

Major Interactions (Avoid): - Warfarin: may increase anticoagulant effect and bleeding risk. - Cyclosporine: possible increase in blood concentrations.

Moderate Interactions (Monitor Closely): - Statins: may enhance risk of myopathy. - Hormonal contraceptives: could reduce efficacy. - Antidiabetic agents: may potentiate hypoglycaemic effect. - Certain antibiotics (e.g., clarithromycin): monitor for altered plasma levels.